Having self-disclosed my own cancer diagnosis (hardly under the same degree of public scrutiny!) I commend Princess Kate's candor in sharing this news that it might inspire others (let alone dispel rumor-mongering about her condition) This patient-oncologist wishes her well!

Saved papers you plan to “read”

Aujourd’hui c'est vendredi, le jour du #ClinicObiome à #GustaveRoussy. Pour améliorer la santé du futur, la Clinique du Microbiote et Cancer analyse le #microbiote pour l'intégrer dans la pratique de soin et développer de nouvelles thérapies ! Voici notre équipe d’aujourd’hui !

We are looking for high quality studies on #precisionmedicine and translational #cancerresearch to be highlighted at #MAP2024 in London. Great opportunity to show your work - poster and oral presentation opportunities, including a dedicated day to research on #AI

join us this October for #MAP2024 in London. It will be a great meeting! Abstract submission is now open until 23-July: esmo.org/meeting-calend… ESMO - Eur. Oncology Science and Innovation at Cancer Research UK Unicancer

Proud 🥹😍🥰of our Fellow Federica Gattazzo! She got the ASCO Merit Award 2024 for our work : ‘Impact of microbiota-specific circulating memory T cells in response to immunotherapy ‘ ! Gustave Roussy #asco Conquer Cancer, the ASCO Foundation Carolina Alves Costa Silva, MD, PhD repubblica.it/salute/dossier…

Microbiota is a crucial piece of ultra-precision medicine while managing pts w cancer. Here, the Gustave Roussy team (lisaderosa) provides with a simple toll to assess dysbiosis 👇 sciencedirect.com/science/articl… Clinical trials ongoing to overcome dysbiosis and restaure IO efficacy

Towards personalized microbiota-centered interventions 🥳 Thanks to lisaderosa and Valerio Iebba for this (long 😅) adventure. Hope you enjoy reading! cell.com/cell/fulltext/…

Just published on Cell, our work led by Gustave Roussy team of Laurence Zitvogel. Enjoy reading the whole article: cell.com/cell/fulltext/… Greateful for the work with all the collaborators!!! lisaderosa, Carolina Alves Costa Silva, MD, PhD, Guido Kroemer, Bertrand Routy MD,PhD, and more...

Listening to Harry Sokol showing exciting data of F. prausnitzii & response to immune-checkpoint blockade (privileged view 🙂) #IHMC2024 #microbiomeclinicians

Join us in London this October for #MAP2024 to discuss the latest developments in precision oncology Hear from this year’s scientific co-chairs on why young oncologists should attend 👇 lisaderosa | Mariam Jamal-Hanjani | @QuimMateo| ESMO - Eur. Oncology |Unicancer A.C. bit.ly/4bFLC8G

The Anna Karenina Principle has been noted at #IHMC 2024 frequently: 'healthy' #microbiomes are similar, while #dysbiosis is more unique. This #microbiome field is complex, complicated, multifactorial, and more! 😬 🦠💩🤓

Dommage que je ne peux pas m’arrêter… Gustave Roussy … je viendrai demain ! #backtowork! #ligne14 #metro #Paris

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome. cell.com/cell/fulltext/… lisaderosa, Valerio Iebba, Carolina Alves Costa Silva, MD, PhD, Bertrand Routy MD,PhD, Fabrice Barlesi, Benjamin Besse, Laurence Albiges, Bernard Escudier, Nicola Segata, Zitvogel & coll.

🚨 Today is your last chance to book your place at #MAP2024 with the early registration discount to join the likes of Mariam Jamal-Hanjani, Joaquin Mateo & lisaderosa – get your ticket now: bit.ly/3K5MyXG ESMO - Eur. Oncology | Unicancer | Gustave Roussy | Vall d’Hebron Institute of Oncology (VHIO) | UCL

A heartfelt Thank you to Alexandra Curioni_Oncology_MD. And thanks to all students, whose energy, ideas and passion have been a true source of inspiration : the importance of staying courious! Jarushka Naidoo George Coukos Solange Peters ETH Zurich Faculty of Science and Medicine Fribourg

Proud of this rising star ⭐️! She presents multi-omics analyses to decifer the clinical relevance of Atb in IO adele bonato #ESMO2024 #Clinicobiome #travelgrantrecipient Gustave Roussy